Endocrine Testing Market Size Projected To Reach $4.01 Billion By 2034 With A Cagr Of 9.5%

The Endocrine Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Endocrine Testing Market?
The endocrine testing market size has grown strongly in recent years. It will grow from $2.55 billion in 2024 to $2.8 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to discovery of hormones and endocrine pathways, diagnostic test standardization, public health initiatives, and patient advocacy and empowerment.

The endocrine testing market is projected to grow significantly, reaching $4.01 billion by 2029, with a CAGR of 9.5%. This growth is driven by the rising prevalence of endocrine disorders, higher defense spending, an aging population, greater awareness, and early diagnosis. Trends include advancements in biomarker detection, the integration of omics technologies, the use of AI and ML, a focus on quality assurance and standardization, and collaborative research and translational medicine.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15562

What Are the Different Endocrine Testing Market Segments?
The endocrine testing market covered in this report is segmented -

1) By Test Type: Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Prolactin Test, Other Types
2) By Technology: Tandem Mass Spectrometry, Immunoassay, Monoclonal And Polyclonal Antibody Technologies, Sensor Technology, Clinical Chemistry, Other Technologies
3) By End-User: Hospitals, Clinical Laboratories, Diagnostic Centers, Other End-Users

Subsegments:
1) By Estradiol (E2) Test: Serum Estradiol Test, Urinary Estradiol Test
2) By Follicle Stimulating Hormone (FSH) Test: FSH Serum Test, FSH Urine Test
3) By Human Chorionic Gonadotropin (hCG) Hormone Test: Quantitative hCG Test, Qualitative hCG Test
4) By Luteinizing Hormone (LH) Test: LH Serum Test, LH Urine Test
5) By Dehydroepiandrosterone Sulfate (DHEAS) Test: Serum DHEAS Test, Saliva DHEAS Test
6) By Progesterone Test: Serum Progesterone Test, Urinary Progesterone Test
7) By Testosterone Test: Free Testosterone Test, Total Testosterone Test
8) By Thyroid Stimulating Hormone (TSH) Test: TSH Serum Test, TSH Saliva Test
9) By Prolactin Test: Serum Prolactin Test, Plasma Prolactin Test
10) By Other Types: Cortisol Test, Insulin Test, Growth Hormone (GH) Test, Aldosterone Test

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15562&type=smp

What Are the Primary Drivers Shaping the Endocrine Testing Market?
The rising prevalence of diabetes is also expected to drive the growth of the endocrine testing market. Diabetes, a condition characterized by high blood sugar levels, is becoming more common due to factors such as poor diets, lack of physical activity, genetics, and an aging population. Endocrine testing, including tests for hemoglobin A1c, fasting plasma glucose, and C-peptide, is essential for diagnosing and managing diabetes. For example, in June 2024, the NHS reported a significant rise in diabetes diagnoses among individuals under 40, from 173,166 in 2022 to 216,440 in 2023. This rapid increase highlights the growing concern of diabetes in younger populations. Therefore, the rising prevalence of diabetes is driving the endocrine testing market.

Which Companies Are Leading in the Endocrine Testing Market?
Major companies operating in the endocrine testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Holding, Siemens Healthineers, Quest Diagnostics, Agilent Technologies Inc., PerkinElmer Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., Qiagen N.V., Ortho Clinical Diagnostics, Kronus Inc., Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Inova Diagnostics Inc., Sekisui Diagnostics LLC, Mercodia AB, ZEUS Scientific Inc., IBL International, Monobind Inc., Agilus Diagnostics, Tosoh Bioscience Inc., DiaSorin S.p.A.

What Are the Latest Developing Trends in the Endocrine Testing Market?
Leading players in the endocrine testing market are innovating with point-of-care testing methods to deepen the accessibility and efficiency of endocrine disorder diagnoses. This type of testing offers quick results, enabling a speedy diagnosis and treatment plan for heart failure cases in patients with symptoms like tiredness and breathlessness. For example, in April 2024, the Swiss pharmaceutical firm, Roche Holding AG, introduced a point-of-care NT-proBNP test in India. This is primarily aimed at screening diabetes patients who are susceptible to cardiovascular complications like heart failure (HF). The test promotes early detection and intervention, allowing healthcare professionals to identify T2D patients with high risk factors and initiate prompt discussions on treatment. This ultimately promotes improved results and the well-being of patients.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/endocrine-testing-global-market-report

What Are the Top Revenue-Generating Geographies in the Endocrine Testing Market?
North America was the largest region in the endocrine testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Endocrine Testing Market?
2. What is the CAGR expected in the Endocrine Testing Market?
3. What Are the Key Innovations Transforming the Endocrine Testing Industry?
4. Which Region Is Leading the Endocrine Testing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.